Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Recilisib | 334969-03-8 | MFCD07366276 | 99.9% | 336.79 g/mol | C16H13ClO4S | 50 MG
SDP

Catalog No. 5000248210
Encompass_Preferred

Recilisib (ON 01210) is a small-molecule radioprotectant reported to activate AKT and PI3K signaling in cells. It is supplied as a high-purity research reagent with recommended solvent guidance and multiple packaging formats for in vitro and in vivo studies.

  • High purity suitable for research use.
  • Activates AKT and PI3K signaling in cellular assays.
  • Soluble in DMSO; protocols available for in vitro and in vivo dosing.
  • Offered as solids, solutions, and sample formats.
  • Multiple package sizes to support screening and scale-up.

Catalog No. 50-002-48210 Supplier Medchemexpress LLC Supplier No. HY10162550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Recilisib (ON 01210) is a small-molecule radioprotectant reported to activate AKT and PI3K signaling in cells. It is supplied as a high-purity research reagent with recommended solvent guidance and multiple packaging formats for in vitro and in vivo studies.

  • High purity suitable for research use.
  • Activates AKT and PI3K signaling in cellular assays.
  • Soluble in DMSO; protocols available for in vitro and in vivo dosing.
  • Offered as solids, solutions, and sample formats.
  • Multiple package sizes to support screening and scale-up.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.